What causes Alzheimer’s disease? A newer immune theory
Quick answer
An emerging view suggests Alzheimer’s may not start in the brain alone. Rather than beta-amyloid being simply harmful, newer models suggest it may be part of the brain’s immune defence, and that systemic immune dysfunction misfiring in the brain could lead to inflammation, synaptic dysfunction and cognitive decline. This is still emerging thinking.
What if Alzheimer’s doesn’t start in the brain at all? For decades, we’ve been told it’s a brain-first disease driven by sticky clumps of beta-amyloid. That story has shaped billions in research and entire drug pipelines — yet real-world outcomes remain disappointing. Emerging thinking suggests a different starting point: systemic immune dysfunction that misfires inside the brain.
Beta-amyloid may be part of the brain’s immune defence — a protector that, under certain conditions, can’t distinguish invaders from neurons.
Rethinking Amyloid: Protector, Not Villain?
According to newer models referenced by researchers such as Professor Donald Weaver, beta-amyloid may act as an immune molecule designed to protect the brain from infection or injury. Problems arise when this defence response targets our own neurons, leading to inflammation, synaptic dysfunction, and ultimately cognitive decline.
This perspective helps explain long-standing puzzles: why some people have abundant plaques with no dementia, while others show cognitive decline with relatively few plaques — and why decades of amyloid-targeting drugs have largely failed to halt disease progression.
Why We Look Beyond the Brain
Your brain is only as healthy as the rest of your body. That’s why our cognoscopy evaluates whole-system drivers that can ignite or sustain neuroinflammation:
- Immune activation & autoimmunity — is your immune system overreacting or misdirected?
- Gut health & microbiome balance — dysbiosis and gut inflammation can amplify brain inflammation.
- Toxic load & detox pathways — heavy metals, moulds, and chemicals affect cognition.
- Mitochondrial & metabolic health — neurons need clean energy and resilient mitochondria.
- Hormones & nutrient status — from oestrogen to B-vitamins, deficits impair signalling and repair.
- Vascular health & insulin sensitivity — “Type 3 diabetes” (brain insulin resistance) damages neurons.
In short: you can’t treat cognitive decline by looking only at the brain.
What You Can Do Now
If you’re concerned about memory or want to be proactive, start with a cognoscopy — a comprehensive evaluation of your brain health through the lens of your whole body. From there, we tailor a plan to reduce inflammation, optimise metabolism, support detoxification, and strengthen neuronal resilience.
Ready to future-proof your brain?
Book your Cognoscopy — a comprehensive, root-cause assessment of your brain and body.
Note: This article reflects emerging models of Alzheimer’s pathophysiology and is for educational purposes only. It is not a substitute for personalised medical advice.
Common questions
Is beta-amyloid the cause of Alzheimer’s?
For decades Alzheimer’s has been described as a brain-first disease driven by beta-amyloid clumps, yet amyloid-targeting drugs have largely failed to halt progression. Newer models, referenced by researchers such as Professor Donald Weaver, suggest amyloid may be an immune molecule that protects the brain.
Why do some people have amyloid plaques but no dementia?
This is one long-standing puzzle: some people have abundant plaques with no dementia, while others show cognitive decline with relatively few plaques. The newer immune-based perspective may help explain this, though it reflects emerging models rather than settled science.
What else can affect inflammation in the brain?
Whole-body drivers that can ignite or sustain neuroinflammation include immune overreaction or autoimmunity, gut health and microbiome balance, toxic load such as heavy metals and moulds, mitochondrial and metabolic health, hormones and nutrient status, and vascular health and insulin sensitivity.
This article is for general information and isn’t a substitute for personal medical advice. Please speak to your GP (family doctor) or a qualified practitioner before making changes to medication or treatment.